Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
agenda, aggrement, Analogue, announced, awaiting, biodistribution, bioengineered, biomaterial, built, clarify, cleanroom, Constance, contrast, DHI, earnable, East, effectivein, endpoint, father, FCA, headcount, height, histology, hyperlipidemia, immunomodulation, impracticable, literature, matrix, multiple, ODI, Orthobond, Oswestry, overt, paracrine, passage, Placebo, point, puncture, PuraCap, rabbit, radiographic, randomized, rebate, Relationship, Responder, SportsCare, Stanley, statistically, Statute, STC, Subscription, telemedicine, theStem, tight, toStem, toxicity, underlyingStem, underwent, Upper, VAS, vi, virtual
Removed:
adulterated, alternatively, Amit, ANDA, ANDMANAGEMENT, Antonio, appointing, cancelled, Cardiothoracic, century, color, commencement, concentrating, conform, conformance, consecutive, consumer, earn, Ember, envision, escalating, executed, execution, fewer, floor, FPLA, half, hand, implicit, initiated, Joel, Jupiter, launched, leased, Maryland, misbranded, monograph, official, Patel, piggyback, protectant, punitive, redeem, reformulation, relabeling, resolution, restraining, San, separately, short, straight, substantiating, successive, sunscreen, supplier, surrender, TDA, truthful, unspecified, Vintage, widespread
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 EX-10.1
- 10.10 EX-10.10
- 10.37 EX-10.37
- 10.58 EX-10.58
- 10.59 EX-10.59
- 10.60 EX-10.60
- 10.61 EX-10.61
- 10.62 EX-10.62
- 10.63 EX-10.63
- 10.64 EX-10.64
- 10.65 EX-10.65
- 10.66 EX-10.66
- 10.67 EX-10.67
- 10.68 EX-10.68
- 10.69 EX-10.69
- 10.70 EX-10.70
- 21 EX-21
- 23 EX-23
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32 EX-32
- Download Excel data file
- View Excel data file
BRTX similar filings
Filing view
External links
Exhibit 10.68
December 14, 2016
John M. Desmarais
26 Deer Creek Lane
Mt. Kisco, New York 10549
Dear John:
Reference is made to the Promissory Note of even date from BioRestorative Therapies, Inc. (the “Company”) to you with respect to a loan made by you to the Company in the amount of $60,000.
In consideration of your loan, the Company agrees that the expiration dates of the Warrants, dated March 18, 2016, issued to you for the purchase of 444,444 and 400,000 shares of the Company’s Common Stock, respectively (the “Warrants”), are extended to December 31, 2018.
Except as modified herein, the Warrants shall continue in full force and effect in accordance with their terms.
Very truly yours, | ||
BioRestorative Therapies, Inc. | ||
By: | ||
Mark Weinreb, Chief Executive Officer |